Lundbeck A/S
(Redirected from Lundbeck)
Jump to navigation
Jump to search
A Lundbeck A/S is a Danish international pharmaceutical company.
- See: Brain Disease, CNS.
References
2022
- (Wikipedia, 2022) ⇒ https://en.wikipedia.org/wiki/Lundbeck Retrieved:2022-8-1.
- H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine.
Headquartered in Copenhagen, Denmark, Lundbeck has 5600 employees in more than 50 countries, and their products are registered in more than 100 countries. They have production facilities in Denmark, France and Italy and their research centers are based in Denmark and the US. Lundbeck generated revenue of DKK 17.7 billion in 2020.
Lundbeck is listed on the Copenhagen Stock Exchange (CSE).
Lundbeck is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
- H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine.